nach oben

Erschienen in:

01.01.2006 | Occasional Survey

Report of an NIH task force on research priorities in chronic kidney disease in children

verfasst von: Russell W. Chesney, Eileen Brewer, Marva Moxey-Mims, Sandra Watkins, Susan L. Furth, William E. Harmon, Richard N. Fine, Ronald J. Portman, Bradley A. Warady, Isidro B. Salusky, Craig B. Langman, Debbie Gipson, Peter Scheidt, Harold Feldman, Frederick J. Kaskel, Norman J. Siegel

Erschienen in: Pediatric Nephrology | Ausgabe 1/2006

Einloggen, um Zugang zu erhalten

Excerpt

This is a summary of the Task Force on Chronic Kidney Disease in Children convened April 24, 2002, by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH) in Bethesda, MD, USA. The goal of this Task Force was to hear expert advice on the value of systematic collection of information about children who have or who are at risk for kidney disease, and to discern research priorities in this area. A panel of 30 experts discussed open and relevant topics in their areas of expertise. A more complete knowledge is needed concerning the definition, etiology, pathogenesis, natural history, epidemiology and therapeutic strategies for chronic kidney disease in children. …

Drozdz D, Drozdz M, Gretz N, Mohring K, Mehls O, Scharer K (1998) Progression to end-stage renal disease in children with posterior urethral valves. Pediatr Nephrol 12:630–636PubMed

Rosen CJ, Ackert-Bicknell C, Beamer WG, Nelson T, Adamo M, Cohen P, Bouxsein ML, Horowitz MC (2005) Allelic differences in a quantitative trait locus affecting insulin-like growth factor-I impact skeletal acquisition and body composition. Pediatr Nephrol 20:255–260PubMed

Davis ID, Baron J, O’Riordan MA, Rosen CL (2005) Sleep disturbances in pediatric dialysis patients. Pediatr Nephrol 20:69–75PubMed

De Palo T, Giordano M, Palumbo F, Bellantuono R, Messina G, Colella V, Caringella AD (2004) Clinical experience with darbepoietin alfa (NESP) in children undergoing hemodialysis. Pediatr Nephrol 19:337–340

Stoll ML, Gauthier BG, Vergara M, Ramek J, Frank R, Trachtman H (2004) Efficacy of losartan in the treatment of erythrocytosis in a young adult with CRF. Pediatr Nephrol 19:120–121PubMed

Everdell NL, Coulthard MG, Crosier J, Keir MJ (2005) A machine for haemodialysing very small infants. Pediatr Nephrol 20:636–643PubMed

Fischbach M, Edefonti A, Schroder C, Watson A (2005) Hemodialysis in children: general practical guidelines. Pediatr Nephrol 20:1054–1066PubMedCentralPubMed

Maroti Z, Nemeth I, Turi S, Karg E, Ugocsai P, Endreffy E (2004) Heme oxygenase 1 expression in young uremic patients on hemodialysis. Pediatr Nephrol 19:426–431PubMed

Taylor CM, Chua C, Howie AJ, Risdon RA (2004) Clinico-pathological findings in diarrhoea-negative haemolytic uraemic syndrome. Pediatr Nephrol 19:419–425PubMed

10.

Malaga S, Pardo R, Malaga I, Orejas G, Fernandez-Toral J (2005) Renal involvement in Down syndrome. Pediatr Nephrol 20:614–617PubMed

11.

Neu AM, Fivush BA, Warady BA, Watkins SL, Friedman AL, Brem AS, Goldstein S, Frankenfield DL (2003) Longitudinal analysis of intermediate outcomes in adolescent hemodialysis patients. Pediatr Nephrol 18:1172–1176PubMed

12.

NAPRTCS Annual Report (2002) http://www.naprtcs.org

13.

U.S. Renal Data System, USRDA 2001 Annual Data Report (2001) Atlas of end-stage renal disease in the United States, National Institutes of Diabetes and Digestive and Kidney Disease. Bethesda, MD, USA, www.usrds.org

14.

Seikaly MG, Ho PL, Emmett L, Fine RN, Tejani A (2003) Chronic renal insufficiency in children: the 2001 Annual Report of the NAPRTCS. Pediatr Nephrol 18:796–804PubMed

15.

Groop L, Orho-Melander M (2001) The dysmetabolic syndrome. J Intern Med 250:105–120PubMed

16.

www.kidney.org/professionals/doqi/guidelineindex.cfm (National Kidney Foundation), Chronic Kidney Disease Guidelines

17.

Fletcher R, Fletcher S, Wagner E (1996) Clinical epidemiology: The essentials, 3rd edn. Williams and Wilkins, Baltimore, pp 135–140

18.

Ahuja TS, Abbott KC, Pack L, Kuo YF (2004) HIV-associated nephropathy and end-stage renal disease in children in the United States. Pediatr Nephrol 19:808–811PubMed

19.

Ardissino G, Testa S, Dacco V, Vigano S, Taioli E, Claris-Appiani A, Procaccio M, Avolio L, Ciofani A, Dello Strologo L, Montini G (2004) Proteinuria as a predictor of disease progression in children with hypodysplastic nephropathy. Data from the Ital Kid Project. Pediatr Nephrol 19:172–177PubMed

20.

Litwin M (2004) Risk factors for renal failure in children with non-glomerular nephropathies. Pediatr Nephrol 19:178–186PubMed

21.

Filler G, Payne RP, Orrbine E, Clifford T, Drukker A, McLaine PN (2005) Changing trends in the referral patterns of pediatric nephrology patients. Pediatr Nephrol 20:603–608PubMed

22.

Gordis L (2000) Epidemiology, 2nd edn. Saunders, Philadelphia

23.

Bakkaloglu SA, Soylemezoglu O, Buyan N, Funahashi T, Elhan AH, Peru H, Fidan K, Yilmaz S, Hasanoglu E (2005) High serum adiponectin levels during steroid-responsive nephrotic syndrome relapse. Pediatr Nephrol 20:474–477PubMed

24.

http://omhrc.gov/healthy2000book/tab8.html (2000) Healthy People 2010

25.

Neu A, Ho P, MacDonald R, Warady B (2002) Chronic dialysis in children and adolescents. The 2001 NAPRTCS Annual Report. Pediatr Nephrol 17:656–663PubMed

26.

Furth SL, Stablein D, Fine RN, Powe NR, Fivush BA (2002) Adverse clinical outcomes associated with short stature at dialysis initiation. A report of the North American Pediatric Renal Transplant Cooperative Study. Pediatrics 109:909–913PubMed

27.

Fine RN, Ho PL, Tejani A (2001) The contribution of renal transplantation to final adult height. A report of the North American Pediatric Cooperative Study (NAPRTCS). Pediatr Nephrol 16:951–961PubMed

28.

Bartosh SM, Fine RN, Sullivan EK (2001) Outcomes after transplantation of young patients with systemic lupus erythematosus. A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Transplantation 72:973–978PubMed

29.

Fine RN, Sullivan EK, Kuntze J, Blethen S, Kohaut E (2000) The impact of recombinant human growth hormone treatment during chronic renal insufficiency on renal transplant recipients. J Pediatr 3:376–382

30.

Brouhard BH, Donaldson LA, Lawry KW, McGowan KRB, Drotar D, David I, Rose S, Cohn RA, Tejani A (2000) Cognitive functioning in children on dialysis and post-transplantation. Pediatr Transplant 4:261–267PubMed

31.

Fivush BA, Jabs K, Neu AM, Sullivan EK, Feld LG, Kohaut E, Fine RN (1998) Chronic renal insufficiency in children and adolescents. The 1996 Annual Report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Pediatr Nephrol 12:328–337PubMed

32.

Warady BA, Hebert D, Sullivan EK, Alexander SR, Tejani A (1997) Renal transplantation, chronic dialysis, and chronic renal insufficiency in children and adolescents. The 1995 Annual Report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Nephrol 11:49–64PubMed

33.

Furth SL, Neu AM, Sullivan EK, Gensler G, Tejani A (1997) Immunization practices in children with renal disease. A report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Nephrol 11:443–446PubMed

34.

van der Heijden BJ, van Dijk PC, Verrier-Jones K, Jager KJ, Briggs JD (2004) Renal replacement therapy in children: data from 12 registries in Europe. Pediatr Nephrol 19:213–221

35.

Chesney RW (2005) The future of pediatric nephrology. Pediatr Nephrol 20:867–871PubMed

36.

Lilien MR, Schroder CH, Levtchenko EN, Koomans HA (2004) Growth hormone therapy influences endothelial function in children with renal failure. Pediatr Nephrol 19:785–789PubMed

37.

Rabkin R, Sun DF, Chen Y, Tan J, Schaefer F (2005) Growth hormone resistance in uremia, a role for impaired JAK/STAT signaling. Pediatr Nephrol 20:313–318PubMed

38.

Santos F, Carbajo-Perez E, Rodriguez J, Fernandez-Fuente M, Molinos I, Amil B, Garcia E (2005) Alterations of the growth plate in chronic renal failure. Pediatr Nephrol 20:330–334PubMed

39.

Waller S, Ledermann S, Trompeter R, van’t Hoff W, Ridout D, Rees L (2003) Catch-up growth with normal parathyroid hormone levels in chronic renal failure. Pediatr Nephrol 18:1236–1241PubMed

40.

Dixon P, Iurilli J, Watson AR, Neill E, Foy J, Martin M (2004) Acceptability of a reformulated renal-specific micronutrient supplement. Pediatr Nephrol 19:1433–1434PubMed

41.

Kari JA, Rees L (2005) Growth hormone for children with chronic renal failure and on dialysis. Pediatr Nephrol 20:618–621PubMed

42.

Norman LJ, Macdonald IA, Watson AR (2004) Optimising nutrition in chronic renal insufficiency—growth. Pediatr Nephrol 19:1245–1252PubMed

43.

Norman LJ, Macdonald IA, Watson AR (2004) Optimising nutrition in chronic renal insufficiency—progression of disease. Pediatr Nephrol 19:1253–1261PubMed

44.

Tönshoff B, Kiepe D, Ciarmatori S (2005) Growth hormone/insulin-like growth factor system in children with chronic renal failure. Pediatr Nephrol 20:279–289

45.

Ellis D (2000) Growth and renal function after steroid-free tacrolimus-based immunosuppression in children with renal transplants. Pediatr Nephrol 14:689–694PubMed

46.

Polinsky M, Kaiser B, Stover J (1987) Neurologic development of children with severe chronic renal failure from infancy. Pediatr Nephrol 1:157–165PubMed

47.

Warady B, Belden B, Kohaut EC (1999) Neurodevelopmental outcome of children initiating peritoneal dialysis in early infancy. Pediatr Nephrol 13:759–765PubMed

48.

Gipson DS, Wetherington CE, Duquette PJ, Hooper SR (2004) The nervous system and chronic kidney disease in children. Pediatr Nephrol 19:832–839PubMedCentralPubMed

49.

Fennell RS, Fennell EB, Carter RL, Mings EL, Klausner AB, Hurst JR (1990) Association between renal function and cognition in childhood chronic renal failure. Pediatr Nephrol 4:16–20PubMed

50.

Lawry KW, Brouhard BH, Cunningham RJ (1994) Cognitive functioning and school performance in children with renal failure. Pediatr Nephrol 8:326–329PubMed

51.

Hulstijn-Dirkmaat GM, Damhuis IH, Jetten ML, Koster AM, Schröder C (1995) The cognitive development of pre-school children treated for chronic renal failure. Pediatr Nephrol 9:464–469PubMed

52.

Eijsermans RM, Creemers DG, Helders PJ, Schröder CH (2004) Motor performance, exercise tolerance, and health-related quality of life in children on dialysis. Pediatr Nephrol 19:1262–1266PubMed

53.

Schärer K, Schmidt KG, Soergel M (1999) Cardiac function and structure in patients with chronic renal failure. Pediatr Nephrol 13:951–965

54.

Mitsnefes MM, Daniels SR, Schwartz SM, Meyer RA, Khoury P, Strife CF (2000) Severe left ventricular hypertrophy in pediatric dialysis: prevalence and predictors. Pediatr Nephrol 14:898–902PubMed

55.

Dursun H, Kucukosmanoglu O, Noyan A, Ozbarlas N, Buyukcelik M, Soran M, Bayazit AK, Anarat A (2005) Mitral annular calcification and brown tumor of the rib in a child with chronic renal failure. Pediatr Nephrol 20:673–675PubMed

56.

Poyrazoglu HM, Dusunsel R, Narin F, Gunduz Z, Narin N, Karakukcu M, Tahan F (2004) Homocysteine and left ventricular hypertrophy in children with chronic renal failure. Pediatr Nephrol 19:193–198PubMed

57.

Hopp L, Gilboa N, Kurland G, Weichler N, Orchard TJ (1994) Acute myocardial infarction in a young boy with nephrotic syndrome: A case report and review of the literature. Pediatr Nephrol 8:290–294PubMed

58.

Adedoyin O, Frank R, Vento S, Vergara M, Gauthier B, Trachtman H (2004) Cardiac disease in children with primary glomerular disorders-role of focal segmental glomerulosclerosis. Pediatr Nephrol 19:408–412PubMed

59.

Parekh RS, Gidding SS (2005) Cardiovascular complications in pediatric end-stage renal disease. Pediatr Nephrol 20:125–131PubMed

60.

Querfeld U (2004) The clinical significance of vascular calcification in young patients with end-stage renal disease. Pediatr Nephrol 19:478–484PubMed

61.

Sheth RD, Perez MD, Goldstein SL (2003) Cardiovascular calcifications in pediatric patients receiving maintenance dialysis. Pediatr Nephrol 18:810–813PubMed

62.

Bennett-Richards K, Katterhorn M, Donald A, Oakley G, Varghese Z, Rees L, Deanfield JE (2002) Does oral folic acid lower total homocysteine levels and improve endothelial function in children with chronic renal failure. Circulation 105:1810–1815PubMed

63.

Müller T, Koeppe S, Arbeiter K, Luckner D, Salzer U, Balzar E, Aufricht C (2003) Serum lipid pattern unifies following renal transplantation in children. Pediatr Nephrol 18:939–942

64.

Metry G, Wikstrom B, Falind S, Sandhagen B, Linde T, Beshara S, Langstrom B, Danielson BG (1999) Effect of normalization of hematocrit on brain circulation and metabolism in hemodialysis patients. J Am Soc Nephrol 10:854–863PubMed

65.

Pickett JL, Theberge DC, Brown WS, Schweitzer SU, Nissenson AR (1999) Normalizing hematocrit in dialysis patients improves brain function. Am J Kidney Dis 33:1122–1130PubMed

66.

MacDougall IC (2000) How to improve survival in pre-dialysis patients. Nephron 85 [Suppl 1]:15–22

67.

Portoles J, Torralbo A, Martin P, Rodrigo J, Herrero JA, Barrientos A (1997) Cardiovascular effects of recombinant human erythropoietin in predialysis patients. Am J Kidney Dis 29:541–548PubMed

68.

Hayashi T, Suzuki A, Shoji T, Togawa M, Okada N, Tsubakihara Y, Imai E, Hori M (2000) Cardiovascular effect of normalizing the hematocrit level during erythropoietin therapy in predialysis patients with chronic renal failure. Am J Kidney Dis 35:250–256PubMed

69.

Moreno F, Aracil FJ, Perez R, Valderrabano F (1996) Controlled study on the improvement of quality of life in elderly hemodialysis patients after correcting end-stage renal disease-related anemia with erythropoietin. Am J Kidney Dis 27:548–556PubMed

70.

Mitsnefes MM, Daniels SR, Schwartz SM, Khoury P, Strife CF (2001) Changes in left ventricular mass in children and adolescents during chronic dialysis. Pediatr Nephrol 16:318–323PubMed

71.

Foley RN, Parfrey PS, Sarnak MJ (1998) Cardiovascular disease in chronic renal disease. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 32:S112–S119PubMed

72.

Roth D, Smith R, Schulman G, Steinman T, Hatch F, Rudnick M, Sloand J, Freedman B, Williams W, Shadur C, Benz R, Teehan BP, Revicki D, Sarokhan B, Abels R (1994) Effects of recombinant human erythropoietin on renal function in chronic renal failure predialysis patients. Am J Kidney Dis 24:777–784PubMed

73.

US Renal Data System: Excerpts from the USRDA 2001 Annual Data Report. Am J Kidney Dis 38 [Suppl 243]:S1–S248

74.

Silverberg DS, Wexler D, Blum M, Keren G, Sheps D, Leibovitch E, Brosh D, Laniado S, Schwartz D, Yachnin T, Shapira I, Garush D, Baruch R, Koifman B, Kaplan C, Steinbruch S, Iaina A (2000) The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function, functional cardiac class, and markedly reduces hospitalizations. J Am Coll Cardio 35:1737–1744

75.

Gerson A, Fivush BA, Kaskel F, Weiss L, Powe NR, Furth SL (2001) Functional outcomes in adolescents with renal failure: assessing a general health status questionnaire. Perit Dial Int 21 [Suppl]:S89

76.

Fadrowski JJ, Furth SL, Fivush BA (2004) Anemia in pediatric dialysis patients in end-stage renal disease network 5. Pediatr Nephrol 19:1029–1034PubMed

77.

Warady BA, Ho M (2003) Morbidity and mortality in children with anemia at initiation of dialysis. Pediatr Nephrol 18:1055–1062PubMed

78.

Gillespie RS, Wolf FM (2004) Intravenous iron therapy in pediatric hemodialysis patients: a meta-analysis. Pediatr Nephrol 19:662–666PubMed

79.

Ruiz-Jaramillo ML, Guizar-Mendoza JM, Gutierrez-Navarro MJ, Dubey-Ortega LA, Amador-Licona N (2004) Intermittent versus maintenance iron therapy in children on hemodialysis: a randomized study. Pediatr Nephrol 19:77–81

80.

Schröder CH (2003) The management of anemia in pediatric peritoneal dialysis patients. Guidelines by an ad hoc European committee. Pediatr Nephrol 18:805–809

81.

Warady BA, Kausz A, Lerner G, Brewer ED, Chadha V, Brugnara C, Dahl NV, Watkins SL (2004) Iron therapy in the pediatric hemodialysis population. Pediatr Nephrol 19:655–661PubMed

82.

Salusky IB, Ramirez JA, Oppenheim W, Gales B, Segre GV, Goodman WG (1994) Biochemical markers of renal osteodystrophy in pediatric patients undergoing CAPD/CCPD. Kidney Int 46:253–258

83.

John MR, Goodman WG, Gao P, Cantor TL, Salusky IB, Juppner H (1999) A novel immunoradiometric assay detects full-length human PTH but not amino-terminally truncated fragments: implications for PTH measurements in renal failure. J Clin Endocrinol Metab 84:4287–4290PubMed

84.

Bakr AM (2004) Bone mineral density and bone turnover markers in children with chronic renal failure. Pediatr Nephrol 19:1390–1393PubMed

85.

Levi R, Silver J (2005) Pathogenesis of parathyroid dysfunction in end-stage kidney disease. Pediatr Nephrol 20:342–345PubMed

86.

Schmitt CP, Homme M, Schaefer F (2005) Structural organization and biological relevance of oscillatory parathyroid hormone secretion. Pediatr Nephrol 20:346–351PubMed

87.

Schoenau E (2005) The “functional muscle-bone unit”: a two-step diagnostic algorithm in pediatric bone disease. Pediatr Nephrol 20:356–359PubMed

88.

Salusky IB, Kuizon BD, Belin TR, Ramirez JQ, Gales B, Segre GV, Goodman WG (1998) Intermittent calcitriol therapy in secondary hyperparathyroidism: A comparison between oral and intraperitoneal administration. Kidney Int 54:907–914PubMed

89.

Kuizon BD, Goodman WG, Juppner H, Boechat I, Nelson P, Gales B, Salusky IB (1998) Diminished linear growth during calcitriol therapy in children undergoing CCPD. Kidney Int 53:205–211PubMed

90.

Cunningham J (2004) New Vitamin D analogues for osteodystrophy in chronic kidney disease. Pediatr Nephrol 19:705–708PubMed

91.

Sanchez CP (2004) Chronotherapy of high-dose active Vitamin D(3): is evening dosing preferable? Pediatr Nephrol 19:722–723PubMed

92.

Waller S, Ridout D, Cantor T, Rees L (2005) Differences between “intact” PTH and 1–84 PTH assays in chronic renal failure and dialysis. Pediatr Nephrol 20:197–199PubMed

93.

Salusky IB, Juppner H (2004) New PTH assays and renal osteodystrophy. Pediatr Nephrol 19:709–713PubMed

94.

Oh J, Wunsch R, Turzer M, Bahner M, Raggi P, Querfeld U, Mehls O, Schaefer F (2002) Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation 106:100–105PubMed

95.

Greenbaum LA, Grenda R, Qiu P, Restaino I, Wojtak A, Paredes A, Benador N, Melnick JZ, Williams LA, Salusky IB (2005) Intravenous calcitriol for treatment of hyperparathyroidism in children on hemodialysis. Pediatr Nephrol 20:622–630PubMed

96.

Drueke TB (2005) Treatment of secondary hyperparathyroidism of dialysis patients with calcimimetics as a valuable addition to established therapeutic means. Pediatr Nephrol 20:399–403PubMed

97.

Goodman WG (2003) Calcimimetic agents and secondary hyperparathyroidism: rationale for use and results from clinical trials. Pediatr Nephrol 18:1206–1210PubMed

98.

Sanchez CP, Kuizon BD, Abdella PA, Juppner H, Salusky IB, Goodman WG (2000) Impaired growth, delayed ossification, and reduced osteoclastic activity in the growth plate of calcium-supplemented rats with renal failure. Endocrinology 141:1536–1544PubMed

99.

Mahdavi H, Kuizon BD, Gales B, Wang HJ, Elashoff RM, Salusky IB (2003) Sevelamer hydrochloride: an effective phosphate binder in dialyzed children. Pediatr Nephrol 18:1260–1264PubMed

100.

Moe SM, Chen NX (2003) Calciphylaxis and vascular calcification: a continuum of extra-skeletal osteogenesis. Pediatr Nephrol 18:969–975PubMed

101.

Rahn KH (2005) The role of calcium antagonists in patients with chronic renal failure. Pediatr Nephrol

102.

Goodman WG, Goldin J, Kuizon BD, Yoon C, Gales B, Sider D, Wang Y, Chung J, Emerick A, Greaser L, Elashoff RM, Salusky IB (2000) Coronary artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 342:1478–1483PubMed

103.

Milliner DS, Zinsmeister AR, Leiberman E, Landing B (1990) Soft tissue calcification in pediatric patients with end-stage renal disease. Kidney Int 38:931–936PubMed

104.

Aggoun Y, Niaudet P, Laffont A, Sidi D, Kachaner J, Bonnett D (2000) Cardiovascular impact of end-stage renal insufficiency. Arch Mal Coeur Vaiss 93:1009–1013PubMed

105.

Awad JA, Morrow JD, Takahashi K, Roberts LJ 2nd (1993) Identification of non-cyclooxygenase-derived prostanoid (F-2 isoprostane) metabolites in human urine and plasma. J Biol Chem 268:4161–4169PubMed

106.

Bennett-Richards K, Katterhorn M, Donald A, Oakley G, Varghese Z, Bruckdorfer K, Deanfield JE, Rees L (2002) Oral L-arginine does not improve endothelial dysfunction in children with chronic renal failure. Kidney Int 62:1372–1378PubMed

107.

Bolton CH, Downs LG, Victory JG, Dwight JF, Tomson CR, Mackness MI, Pinkney JH (2001) Endothelial dysfunction in chronic renal failure: roles of lipoprotein oxidation and pro-inflammatory cytokines. Nephrol Dial Transplant 16:1189–1197PubMed

108.

Kari J, Donald A, Vallance D, Bruckdorfer K, Leone A, Mullen M, Bunce T, Dorado B, Deanfield JE, Rees L (1997) Physiology and biochemistry of endothelial function in children with chronic renal failure. Kidney Int 52:468–472PubMed

109.

Lilien MR, Stroes ES, Op’t Roodt J, deJongh S, Schroeder CH, Koomans HA (2003) Vascular function in children after renal transplantation. Am J Kidney Dis 41:684–691PubMed

110.

Misselwitz J, Franke S, Kauf E, John U, Stein G (2002) Advanced glycation end products in children with chronic renal failure and type 1 diabetes. Pediatr Nephrol 17:316–321PubMed

111.

Nairn J, Hodge G, Henning P (2005) Changes in leukocyte subsets: clinical implications for children with chronic renal failure. Pediatr Nephrol 20:190–196PubMed

112.

Nayir A, Bilge I, Kilicaslan I, Ander H, Emre S, Sirin A (2001) Arterial changes in paediatric haemodialysis patients undergoing renal transplantation. Nephrol Dial Transplant 16:2041–2047PubMed

113.

Panichi V, Migliori M, De Pietro S, Taccola D, Bianchi AM, Norpoth M, Metelli MR, Giovannini L, Tetta C, Palla R (2001) C-reactive protein in patients with chronic renal diseases. Ren Fail 23:551–562PubMed

114.

Parikh A, Sochett EB, McCrindle BW, Dipchand A, Daneman A, Daneman D (2000) Carotid artery distensibility and cardiac function in adolescents with type 1 diabetes. J Pediatr 137:465–469PubMed

115.

Sebokova K, Podracka L, Heidland A, Schinzel R (2001) Enhanced plasma levels of advanced glycation end products (AGE) and pro-inflammatory cytokines in children/adolescents with chronic renal insufficiency and after renal replacement therapy by dialysis and transplantation: Are they interrelated? Clin Nephrol 56 [Suppl 1]:S21–S26

116.

Spittle MA, Hoenich NA, Handelman GJ, Adhikarla R, Homel P, Levin NW (2001) Oxidative stress and inflammation in hemodialysis patients. Am J Kidney Dis 38:1408–1413PubMed

117.

Wever R, Boer P, Hijmering M, Stroes E, Verhaar M, Kastlein J, Versluis K, Lagerwerf F, van Rijn H, Koomans H, Rabelink T (1999) Nitric oxide production is reduced in patients with chronic renal failure. Arterioscler Thromb Vasc Biol 19:1168–1172PubMed

118.

Yan SD, Schmidt AM, Anderson G (1994) Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors binding protein. J Biol Chem 269:9889–9897PubMed

119.

Zwolinska D, Medynska A, Szprynger K, Szczepanska M (2000) Serum concentration of IL-2, IL-6, TNF-alpha and their soluble receptors in children on maintenance hemodialysis. Nephron 86:441–446PubMed

120.

Dotsch J, Nusken K, Schroth M, Rascher W, Meissner U (2005) Alterations of leptin and ghrelin serum concentrations in renal disease: simple epiphenomena? Pediatr Nephrol 20:701–706PubMed

121.

Musial K, Zwolinska D, Polak-Jonkisz D, Berny U, Szprynger K, Szczepanska M (2005) Serum VCAM-1, ICAM-1, and L-selectin levels in children and young adults with chronic renal failure. Pediatr Nephrol 20:52–55PubMed

122.

Tan JC, Rabkin R (2005) Suppressors of cytokine signaling in health and disease. Pediatr Nephrol 20:567–575PubMed

123.

Zachwieja J, Zaniew M, Bobkowski W, Stefaniak E, Warzywoda A, Ostalska-Nowicka D, Dobrowolska-Zachwieja A, Lewandowska-Stachowiak M, Siwinska A (2005) Beneficial in vitro effect of N-acetyl-cysteine on oxidative stress and apoptosis. Pediatr Nephrol 20:725–731PubMed

124.

www.nationalchildrensstudy.gov (National Children’s Study)

125.

Lucke T, Marwedel KM, Kanzelmeyer NK, Hori A, Offner G, Kreipe HH, Ehrich JH, Das AM (2004) Generalized atherosclerosis sparing the transplanted kidney in Schimke disease. Pediatr Nephrol 19:672–675PubMed

126.

Stein R, Wiesner C, Beetz R, Schwarz M, Thuroff JW (2005) Urinary diversion in children and adolescents with neurogenic bladder: the Mainz experience. Part III: Colonic conduit. Pediatr Nephrol 20:932–936PubMed

127.

Stein R, Wiesner C, Beetz R, Schwarz M, Thuroff JW (2005) Urinary diversion in children and adolescents with neurogenic bladder: the Mainz experience. Part I: Bladder augmentation and bladder substitution--therapeutic algorisms. Pediatr Nephrol 20:920–925PubMed

128.

Barlow WE, Ichikawa L, Rosner D, Izumi S (1999) Analysis of case-cohort designs. J Clin Epidemiol 52:1165–1172PubMed

129.

Therneau TM, Li H (1999) Computing the Cox model for case cohort designs. Lifetime Data Anal 5:99–112PubMed

130.

Gulati S, Kumar A, Sharma RK, Gupta A, Bhandari M, Kumar A, Srivastava A (2004) Outcome of pediatric renal transplants in a developing country. Pediatr Nephrol 19:96–100PubMed

131.

Verrina E, Edefonti A, Gianoglio B, Rinaldi S, Sorino P, Zacchello G, Lavoratti G, Maringhini S, Pecoraro C, Calevo MG, Turrini Dertenois L, Perfumo F (2004) A multicenter experience on patient and technique survival in children on chronic dialysis. Pediatr Nephrol 19:82–90PubMed

Titel: Report of an NIH task force on research priorities in chronic kidney disease in children
verfasst von: Russell W. Chesney
Eileen Brewer
Marva Moxey-Mims
Sandra Watkins
Susan L. Furth
William E. Harmon
Richard N. Fine
Ronald J. Portman
Bradley A. Warady
Isidro B. Salusky
Craig B. Langman
Debbie Gipson
Peter Scheidt
Harold Feldman
Frederick J. Kaskel
Norman J. Siegel
Publikationsdatum: 01.01.2006
Verlag: Springer-Verlag
Erschienen in: Pediatric Nephrology / Ausgabe 1/2006
Print ISSN: 0931-041X
Elektronische ISSN: 1432-198X
DOI: https://doi.org/10.1007/s00467-005-2087-2

Neu im Fachgebiet Pädiatrie

23.04.2024 | Typ-1-Diabetes | Nachrichten

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Report of an NIH task force on research priorities in chronic kidney disease in children

Excerpt

Neu im Fachgebiet Pädiatrie

Neuer Typ-1-Diabetes bei Kindern am Wochenende eher übersehen

Neue Studienergebnisse zur Myopiekontrolle mit Atropin

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

Update Pädiatrie

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2006

Factors affecting histological regression of crescentic Henoch–Schönlein nephritis in children

Our case with IgA deficiency and membranous glomerulonephritis

A seasonal message

Membranoproliferative glomerulonephritis in a patient with X-linked agammaglobulinemia

The 9th Asian Congress of Pediatric Nephrology, 28 - 30 October 2005, Beijing, China

Chloroacetaldehyde- and acrolein-induced death of human proximal tubule cells

Neu im Fachgebiet Pädiatrie

Neuer Typ-1-Diabetes bei Kindern am Wochenende eher übersehen

Neue Studienergebnisse zur Myopiekontrolle mit Atropin

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

Update Pädiatrie